- Home
- NKTX vs ARQQ Comparison
NKTX vs ARQQ Comparison
Compare NKTX & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- ARQQ
- Stock Information
- Founded
- NKTX 2015
- ARQQ 2017
- Country
- NKTX United States
- ARQQ United Kingdom
- Employees
- NKTX N/A
- ARQQ N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- ARQQ Computer Software: Prepackaged Software
- Sector
- NKTX Health Care
- ARQQ Technology
- Exchange
- NKTX Nasdaq
- ARQQ Nasdaq
- Market Cap
- NKTX 170.8M
- ARQQ 173.1M
- IPO Year
- NKTX 2020
- ARQQ N/A
- Fundamental
- Price
- NKTX $2.00
- ARQQ $15.38
- Analyst Decision
- NKTX Strong Buy
- ARQQ Strong Buy
- Analyst Count
- NKTX 6
- ARQQ 1
- Target Price
- NKTX $15.00
- ARQQ $52.00
- AVG Volume (30 Days)
- NKTX 2.4M
- ARQQ 546.4K
- Earning Date
- NKTX 03-26-2025
- ARQQ 05-19-2025
- Dividend Yield
- NKTX N/A
- ARQQ N/A
- EPS Growth
- NKTX N/A
- ARQQ N/A
- EPS
- NKTX N/A
- ARQQ N/A
- Revenue
- NKTX N/A
- ARQQ $293,000.00
- Revenue This Year
- NKTX N/A
- ARQQ $1,818.77
- Revenue Next Year
- NKTX N/A
- ARQQ N/A
- P/E Ratio
- NKTX N/A
- ARQQ N/A
- Revenue Growth
- NKTX N/A
- ARQQ N/A
- 52 Week Low
- NKTX $1.31
- ARQQ $3.72
- 52 Week High
- NKTX $11.84
- ARQQ $52.79
- Technical
- Relative Strength Index (RSI)
- NKTX 59.36
- ARQQ 46.88
- Support Level
- NKTX $1.31
- ARQQ $16.50
- Resistance Level
- NKTX $2.34
- ARQQ $20.70
- Average True Range (ATR)
- NKTX 0.15
- ARQQ 2.45
- MACD
- NKTX 0.05
- ARQQ 0.26
- Stochastic Oscillator
- NKTX 66.99
- ARQQ 36.39
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.